Clinical reviewer
Doctor of Pharmacy · clinical content reviewer
Patricia Weiser is a Doctor of Pharmacy (PharmD), licensed pharmacist, and independent health content writer and medical reviewer. She reviews Pallas's clinical education content for accuracy and balance.
Patricia earned her PharmD from the University of Pittsburgh and is a licensed pharmacist in Pennsylvania. Over more than 15 years in pharmacy practice — including staff and pharmacy-manager roles across community, independent, and hospital settings — she helped patients and caregivers manage their medications, navigate cost and coverage concerns, and access immunization services.
In practice she repeatedly saw that patients' medication concerns often came down to needing clearer information. That observation led her to focus on creating plain-language health content that helps people understand their medications, supplements, and treatment options. Her work has been featured in outlets including US News & World Report, Healthline, Verywell Health, and GoodRx.
On Pallas, Patricia reviews articles on GLP-1 therapy — how semaglutide and tirzepatide work, their evidence base, side effects, and safe use — to ensure they reflect current clinical literature. She does not provide medical care to Pallas patients or prescribe medication; clinical care is delivered by the licensed providers described on the clinical disclosures page.
Articles reviewed by Patricia Weiser
A clear, plain-English explanation of the gut hormones behind modern obesity medicine — how GLP-1 and GIP signal fullness, why hitting two receptors works better than one, and where the science is heading next.
10 min readCompounded semaglutide and tirzepatide vs. FDA-approved Wegovy® and Zepbound®: how they're regulated, made, and priced — and which fits your situation.
10 min readWeek by week, what actually happens in your first 90 days on semaglutide or tirzepatide — side effects, weight loss pace, titration, and how to set yourself up for success.
11 min readA clinical guide to GLP-1 side effects — what's common, what's rare, what's serious, how long they last, and what you can do to make them manageable.
9 min readA clinical comparison of semaglutide and tirzepatide — including the SURMOUNT-5 head-to-head trial, how they work, effectiveness, side effects, cardiovascular benefits, cost, and which one might be right for you.
14 min read